News Archive
If the Objective is Herd Immunity, on Whom Should it be Built?
|
Policy Brief
| News
In the absence of a treatment or vaccine, there are two options available for managing Covid-19: long confinement of a large proportion of the population and the associated economic costs (Plan A), or to progressively build herd immunity by exposing the population to the virus (Plan B). But attaining herd immunity requires governments to expose a fraction of the population to the virus, and to recognize that some people in this targeted population will die.
Covid-19: Has the Time Come for Mainstream Macroeconomics to Rehabilitate Money Printing?
|
Policy Brief
| News
The expenditure necessary to avoid the Covid-19 health crisis turning into a long-lasting deep recession is enormous and raises the issue of how it should be financed: through new debt, or monetization? Monetization - defined as the financing of public expenditure through money creation by the central bank without being reimbursed by the government - has long been rejected by mainstream macroeconomics. Axelle Arquié (EconPol Europe, CEPII), Jérôme Héricourt (EconPol Europe, Université de Lille & CEPII) and Fabien Tripier (EconPol Europe, Université Paris-Sa
Labor Productivity in State-Owned Enterprises
|
Working Paper
| News
Between 2013 and 2015, in the aftermath of the global financial crisis, the Portuguese government revoked four holidays for public and private employees - but the revocation seems to have served little economic purpose and been no more than a ceremonial gesture. In this paper, authors António Afonso (EconPol Europe, Universidade de Lisboa; REM/UECE), Maria João Guedes (Universidade de Lisboa; Advance/CSG), Pankaj C.
COVID-19: The World Economy Needs a Lifeline – But Which One?
|
EconPol Policy Brief
| News
Dorine Boumans, Sebastian Link and Stefan Sauer (EconPol Europe, ifo Institute) surveyed 1000 economic experts in 110 countries on the economic effects of the COVID-19 pandemic and the effectiveness of different policy measures to combat the crisis for different countries.
ESM Liquidity Assistance Versus Corona Bonds
|
EconPol Policy Briefs
| News
In the search for the right European financing instruments, the purported advantages of corona bonds over the ESM are meagre to non-existent, says Friedrich Heinemann (EconPol Europe, ZEW): the challenge we face is to contain the spread of COVID-19 while stabilising the economy and ensuring eurozone states have sufficient liquidity, and the ESM is a suitable tool for pursuing these ends.